The Novo Nordisk Foundation supports the Steno Diabetes Centers based on the vision of ensuring that people with diabetes live longer with an enhanced quality of life and that fewer people develop diabetes. Through a research-based approach, the Foundation also wants to contribute to making Denmark a global leader in patient-centred treatment of diabetes.
Steno Diabetes Centers have been established in the five administrative regions of Denmark, as well as in Greenland and the Faroe Islands. This puts the Steno Diabetes Centers on the map throughout the Danish Realm.
Each centre is based on the specific conditions that apply in each region or in Greenland or the Faroe Islands. The involvement of patients is central to planning the activities and physical framework of the centres.
The Foundation has awarded grants totalling DKK 7.4 billion to the administrative regions in Denmark for establishing and operating the regional Centers. The Foundation has also awarded grants totalling DKK 382 million to establish Steno Diabetes Center Greenland (Inuunerissaavik Steno Kalaallit Nunaat) in Nuuk, and DKK 123 million for Steno Diabetes Center Faroe Islands. The grants cover treatment, research, education, cross-sectoral collaboration, and the construction of new buildings.
